The COVID-19 pandemic emphasized the need for access to reliable and cost-effective virus detection. Virus detection techniques typically look for nucleic acids within samples, using protocols designed to isolate viral RNA for downstream nucleic acid detection and analysis. Scientists can either adapt previously established RNA extraction techniques for viral samples or develop new strategies and reagents centered on viral RNA extraction. In this webinar, brought to you by MilliporeSigma, Nicolas Caffarelli and Kan Saito will describe how previously developed RNA extraction kits can be optimized and validated for easy, sensitive viral RNA purification and detection. They will also highlight recently developed reagents, including a novel viral RNA extraction buffer that can be mixed directly with virus-containing sample, allowing for rapid room-temperature lysis and RNA detection without the need for further clean up.
Topics to be covered
Column-based viral RNA extraction strategies
Rapid direct viral lysis for RNA detection
qRT-PCR kits compatible with sensitive SARS-CoV-2 detection
Wednesday, June 16, 2021
11:00 AM - 12:30 PM, Eastern Time
Speakers
Nicolas Caffarelli R&D Senior Scientist MilliporeSigma
Kan Saito, PhD R&D Scientist MilliporeSigma
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Register Now
TS_Webinar_MilliporeSigma_Approaches to Processing SARS-CoV-2 Samples for RNA Detection June 16, 2021
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
.jpg?width=990&name=990x120%20(v3).jpg "990x120 (v3)")
